Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Gerpang Biotechnology is a private healthcare and biotechnology company based in Jinan, Shandong, China. Publicly available sources describe it as a subsidiary or affiliate within Gerpang Healthcare Group, with activities spanning biomedical research and development, medical device and therapeutic instrument commercialization, medical software development, health information services, and drug and medical device development. The company has also been referenced in connection with rehabilitation services, low-frequency therapeutic instruments, intelligent rehabilitation offerings, and prospective work in gene technology, immunotherapy, and stem cell transplantation-related applications. Available evidence suggests the business is more diversified healthcare and medtech oriented than a pure-play drug developer, and detailed drug pipeline disclosures are not readily available. It appears to be active and privately held, with operations centered in Jinan's high-tech and pharmaceutical park ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Gerpang Biotechnology.